Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome since obesity and insulin resistance are the main pathogenic contributors for both conditions. NAFLD carries increased risk of atherosclerosis and cardiovascular diseases. There is an urgent need to...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Janczyk, Wojciech, Socha, Piotr, Lebensztejn, Dariusz, Wierzbicka, Aldona, Mazur, Artur, Neuhoff-Murawska, Joanna, Matusik, Pawel
Formáid: Artigo
Teanga:Inglês
Foilsithe: BioMed Central 2013
Ábhair:
Study Protocol
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3672084/
https://ncbi.nlm.nih.gov/pubmed/23702094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-13-85
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla